Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Translational Medicine, Data Access and Pharmaceutical Innovation

Posted on January 17th, 2018 by

Pharma R&D

translational medicine

Some of the early seeds of translational medicine were planted in 1992 when the U.S. National Cancer Institute introduced a program designed to improve and accelerate the knowledge exchange between basic and clinical science. Continue reading “Translational Medicine, Data Access and Pharmaceutical Innovation” »

A Hackathon Demonstrates the Need for Deep Learning in R&D

Posted on January 12th, 2018 by

Pharma R&D

binary-2372130_1920

Today’s life science companies find themselves dealing with an interesting dilemma. With the help of many technological breakthroughs, they now have access to tons of data bursting with potential. Continue reading “A Hackathon Demonstrates the Need for Deep Learning in R&D” »

Companies and Investors Gather in San Francisco for J.P. Morgan Healthcare Conference January 8-11

Posted on January 9th, 2018 by

Pharma R&D

san-francisco-51002_1280

Healthcare companies and investors are flocking to San Francisco from January 8-11 for the 36th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel. Continue reading “Companies and Investors Gather in San Francisco for J.P. Morgan Healthcare Conference January 8-11” »

Solving Global Research Challenges with Artificial Intelligence

Posted on January 8th, 2018 by

Pharma R&D

board-1364652_1280

In the 21st century, we are facing a number of enormous global challenges. Simply producing enough food and clean water to nourish the planet’s growing population is one of the biggest difficulties. Meanwhile, we must also deal with the ravages of climate change and take on medical problems like antibiotic resistance. Continue reading “Solving Global Research Challenges with Artificial Intelligence” »

Unifying Data Standards to Promote Innovation

Posted on January 5th, 2018 by

Pharma R&D

blur-1853262_1280

Imagine that you are spending your days as a researcher in the life sciences, trying to use your skills, expertise and determination to do innovative, potentially life-saving work, but then you keep getting bogged down by the “busy work” of having to clean up data. Continue reading “Unifying Data Standards to Promote Innovation” »

Quantitative Proteomics: A Major Piece in the Precision Medicine Puzzle

Posted on December 22nd, 2017 by

Pharma R&D

dna-1811955_960_720

Our genetic make-up, where we live and how we live, are all important factors to consider when we are dealing with disease. For a very long time, medicine has mostly been designed to treat the sickness without much thought to the individual who has it. Continue reading “Quantitative Proteomics: A Major Piece in the Precision Medicine Puzzle” »

  1. 1
  2. 2
  3. 3
  4. 53


About this Blog

iStock_000019748868_Full

The Elsevier Pharma R&D blog provides insight and opinion on topics related to pharmaceutical research and development, namely: big data, target identification, new drug discovery, drug safety monitoring, risk mitigation and regulatory compliance. We serve the community of chemists, scientists, drug safety specialists, educators and students interested in pharmaceutical R&D.

Editor’s note: The views and opinions expressed are those of the author and do not necessarily reflect the views of Elsevier,  its affiliates and sponsors or its parent company, Reed Elsevier.